TipRanks on MSN2d
AdAlta Limited Unveils Strategic ‘East to West’ Cellular Immunotherapy Approach
AdAlta Ltd. ( ($AU:1AD) ) just unveiled an announcement. AdAlta Limited is set to host an investor webinar to discuss its ‘East to West’ cellular ...
HotCopper.com on MSN2d
'East to West': AdAlta unveils new strategy to find drug candidates, but appears to've ditched AD-214
AdAlta (ASX:1AD) has unveiled a new grand plan to take cell therapy candidates from Southeast Asia, firm them up in ...
stockhead2d
AdAlta prioritises ‘East to West’ cellular immunotherapy strategy to drive value creation
AdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.
stockhead8d
AdAlta boosts leadership in Q2 FY25 to support growth strategy
FY25 saw AdAlta (ASX:1AD) focus on increasing its corporate muscle, with two new board members and additional advisors ...
Business Insider29d
AdAlta to Present at Biotech Showcase 2025 During JPMorgan Healthcare Week
Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener AdAlta Ltd ...
Yahoo Finance1mon
Insider Traders Lose AU$43k As AdAlta Drops
The recent price decline of 12% in AdAlta Limited's (ASX:1AD) stock may have disappointed insiders who bought AU$99.5k worth of shares at an average price of AU$0.026 in the past 12 months. Insiders ...